Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Price Is Right But Growth Is Lacking After Shares Rocket 105%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
Dow Falls 150 Points; Oracle Posts Downbeat Results
Wall Street Set to Open Flat Tuesday as Investors Await Inflation Data
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday
U.S. Stock Outlook | The three major futures are mixed, Citigroup predicts the S&P 500 could reach a high of 6900 points next year; Chinese concept stocks and ETFs are generally down in pre-market trading, with YINN falling over 11%.
NVIDIA responds to being investigated: happy to answer any questions regulators have for us; demand for AI Chips is driving growth! Taiwan Semiconductor's sales in November saw a year-on-year increase of 34%, but a quarter-on-quarter decline; deficits are concerning! Bond giant Pimco: cut positions in long-term US Bonds, shifting to medium-term bonds and overseas bonds.
Investors Look Ahead to Key Inflation Data as US Futures Tread Water in Tuesday's Premarket
Top Premarket Gainers
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Cumberland Pharma Shares Rise 56% After FDA Approves Liver Drug Acetadote
Express News | Cumberland Pharmaceuticals Inc - New Dosing Regimen Simplifies Acetadote Administration
Cumberland Pharmaceuticals Shares Are Trading Higher After the Company Announced the FDA Has Approved Its Supplemental New Drug Application for Acetadote.
Express News | FDA Approves Acetadote® Snda
Cumberland Pharmaceuticals Gets FDA Approval Of Acetadote, An Antidote To Prevent Or Lessen Hepatic Injury From Acetaminophen Overdose, For Pediatric Patients
US Manufacturing Index Rises To 43, Highest Since 2020
Cumberland Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Cumberland Pharmaceuticals Reports Q3 2024 Earnings and Developments
Cumberland Q3 Adj $(0.02) Down From $0.02 YoY, Sales $9.09M Down From $10.09M YoY